AURA
Price
$10.04
Change
-$0.29 (-2.81%)
Updated
Nov 14, 11:42 AM (EDT)
118 days until earnings call
HOWL
Price
$2.05
Change
-$0.10 (-4.65%)
Updated
Nov 13 closing price
126 days until earnings call
Ad is loading...

AURA vs HOWL

Header iconAURA vs HOWL Comparison
Open Charts AURA vs HOWLBanner chart's image
Aura Biosciences
Price$10.04
Change-$0.29 (-2.81%)
Volume$812
CapitalizationN/A
Werewolf Therapeutics
Price$2.05
Change-$0.10 (-4.65%)
Volume$686.23K
CapitalizationN/A
AURA vs HOWL Comparison Chart
Loading...
AURA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
HOWL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
AURA vs. HOWL commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AURA is a Sell and HOWL is a Hold.

COMPARISON
Comparison
Nov 14, 2024
Stock price -- (AURA: $10.33 vs. HOWL: $2.05)
Brand notoriety: AURA and HOWL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AURA: 62% vs. HOWL: 86%
Market capitalization -- AURA: $512.43M vs. HOWL: $91.35M
AURA [@Biotechnology] is valued at $512.43M. HOWL’s [@Biotechnology] market capitalization is $91.35M. The market cap for tickers in the [@Biotechnology] industry ranges from $473.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AURA’s FA Score shows that 0 FA rating(s) are green whileHOWL’s FA Score has 1 green FA rating(s).

  • AURA’s FA Score: 0 green, 5 red.
  • HOWL’s FA Score: 1 green, 4 red.
According to our system of comparison, AURA is a better buy in the long-term than HOWL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AURA’s TA Score shows that 2 TA indicator(s) are bullish while HOWL’s TA Score has 3 bullish TA indicator(s).

  • AURA’s TA Score: 2 bullish, 6 bearish.
  • HOWL’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, both AURA and HOWL are a bad buy in the short-term.

Price Growth

AURA (@Biotechnology) experienced а -6.09% price change this week, while HOWL (@Biotechnology) price change was -15.98% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.92%. For the same industry, the average monthly price growth was +4.38%, and the average quarterly price growth was +6.91%.

Reported Earning Dates

AURA is expected to report earnings on Mar 12, 2025.

HOWL is expected to report earnings on Mar 20, 2025.

Industries' Descriptions

@Biotechnology (-0.92% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AURA($512M) has a higher market cap than HOWL($91.4M). AURA YTD gains are higher at: 16.591 vs. HOWL (-46.891). HOWL has higher annual earnings (EBITDA): -47.75M vs. AURA (-89.06M). AURA has more cash in the bank: 187M vs. HOWL (135M). AURA has less debt than HOWL: AURA (19M) vs HOWL (36.7M). HOWL has higher revenues than AURA: HOWL (9.28M) vs AURA (0).
AURAHOWLAURA / HOWL
Capitalization512M91.4M560%
EBITDA-89.06M-47.75M187%
Gain YTD16.591-46.891-35%
P/E RatioN/AN/A-
Revenue09.28M-
Total Cash187M135M139%
Total Debt19M36.7M52%
TECHNICAL ANALYSIS
Technical Analysis
AURAHOWL
RSI
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
87%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
73%
Momentum
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
84%
MACD
ODDS (%)
Bearish Trend 1 day ago
76%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 9 days ago
78%
Bullish Trend 30 days ago
81%
Declines
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
85%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
AURA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
HOWL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NINOY12.570.22
+1.78%
Nikon Corp.
TELNY11.89-0.14
-1.16%
Telenor ASA
SMBC66.19-0.86
-1.28%
Southern Missouri Bancorp
IZM2.20-0.03
-1.35%
ICZOOM Group
DBOEY21.93-0.33
-1.48%
Deutsche Boerse AG

HOWL and

Correlation & Price change

A.I.dvisor indicates that over the last year, HOWL has been loosely correlated with ABOS. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if HOWL jumps, then ABOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HOWL
1D Price
Change %
HOWL100%
-4.65%
ABOS - HOWL
36%
Loosely correlated
-5.42%
AURA - HOWL
36%
Loosely correlated
-3.00%
GBIO - HOWL
36%
Loosely correlated
-10.73%
KRRO - HOWL
34%
Loosely correlated
-15.55%
GNPX - HOWL
33%
Loosely correlated
-23.44%
More